ABIVAX Société Anonyme Statistics

Total Valuation

ABIVAX Société Anonyme has a market cap or net worth of EUR 447.16 million. The enterprise value is 338.20 million.

Market Cap	447.16M
Enterprise Value	338.20M

Important Dates

The next estimated earnings date is Friday, March 14, 2025.

Earnings Date	Mar 14, 2025
Ex-Dividend Date	n/a

Share Statistics

ABIVAX Société Anonyme has 63.34 million shares outstanding. The number of shares has increased by 97.36% in one year.

Current Share Class	n/a
Shares Outstanding	63.34M
Shares Change (YoY)	+97.36%
Shares Change (QoQ)	+25.27%
Owned by Insiders (%)	3.62%
Owned by Institutions (%)	29.83%
Float	30.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	44.23
PB Ratio	3.51
P/TBV Ratio	4.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.91
EV / Sales	37.45
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.18

Financial Position

The company has a current ratio of 3.04, with a Debt / Equity ratio of 0.90.

Current Ratio	3.04
Quick Ratio	2.98
Debt / Equity	0.90
Debt / EBITDA	n/a
Debt / FCF	-0.73
Interest Coverage	-15.83

Financial Efficiency

Return on equity (ROE) is -171.46% and return on invested capital (ROIC) is -57.12%.

Return on Equity (ROE)	-171.46%
Return on Assets (ROA)	-46.69%
Return on Capital (ROIC)	-57.12%
Revenue Per Employee	145,661
Profits Per Employee	-2.86M
Employee Count	61
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.47% in the last 52 weeks. The beta is 1.45, so ABIVAX Société Anonyme's price volatility has been higher than the market average.

Beta (5Y)	1.45
52-Week Price Change	-24.47%
50-Day Moving Average	8.62
200-Day Moving Average	11.19
Relative Strength Index (RSI)	33.02
Average Volume (20 Days)	23,163

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ABIVAX Société Anonyme had revenue of EUR 9.03 million and -177.43 million in losses. Loss per share was -3.14.

Revenue	9.03M
Gross Profit	9.03M
Operating Income	-170.17M
Pretax Income	-177.43M
Net Income	-177.43M
EBITDA	-169.87M
EBIT	-170.17M
Loss Per Share	-3.14

Full Income Statement

Balance Sheet

The company has 222.32 million in cash and 113.36 million in debt, giving a net cash position of 108.96 million or 1.72 per share.

Cash & Cash Equivalents	222.32M
Total Debt	113.36M
Net Cash	108.96M
Net Cash Per Share	1.72
Equity (Book Value)	126.47M
Book Value Per Share	2.01
Working Capital	163.02M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -154.71 million and capital expenditures -353,000, giving a free cash flow of -155.06 million.

Operating Cash Flow	-154.71M
Capital Expenditures	-353,000
Free Cash Flow	-155.06M
FCF Per Share	-2.45

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-1,884.32%
Pretax Margin	-1,964.62%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ABIVAX Société Anonyme does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-97.36%
Shareholder Yield	-97.36%
Earnings Yield	-44.42%
FCF Yield	-34.68%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ABIVAX Société Anonyme has an Altman Z-Score of -0.27. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.27
Piotroski F-Score	n/a